USPTO serial 97621899
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $600
Stockholm, SE
Stockholm, SE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cecilia R. Dickson
Cecilia R. Dickson The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software and hardware for medical and diagnostic use for monitoring and analyzing patient data points from the health records; Downloadable computer software for evaluating, verifying, monitoring, analysis and management of medical data; Downloadable computer software for medical equipment, in particular in diagnostic and prognostic equipments indicating level risk of sepsis; Downloadable AI software for diagnostics, monitoring and data analysis; Downloadable computer software for use with medical patient monitoring, diagnostic and prognostic equipment for receiving, processing, transmitting, analyzing, organizing and displaying data; Downloadable computer software for enabling the secure and efficient transfer of tests and data between patients and caregivers; Downloadable medical software applications for body fluid monitoring; Downloadable computer software for monitoring, tracking, inserting, archiving, analyzing, preparing of reports, comparing and sharing of medical information and data; Computer hardware with preinstalled software for providing a risk score to health care providers with regards to a patients sepsis risk; Electronic data recorders for collection and management of physiological and medical data, namely data originating from electronic health records; Electronic data recorders for measuring, detecting, receiving, monitoring, transmitting and processing of data, namely data originating from electronic health records | ACTIVE | — |
| 010 | Medical equipment for diagnostics, examination, analyzing and monitoring patient health conditions, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical apparatus and instruments for diagnosing, monitoring and analyzing of patients who are at risk for or who have medically destabilizing conditions, systemic inflammatory diseases, sepsis and infection, other immunological conditions or organ dysfunction or failure, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical equipment and apparatus equipped with communication platforms for continuous and remote monitoring of physiological parameters, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Diagnostic and prognostic apparatus for medical purposes, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical equipment for analyzing, storing, transmitting and organizing of medical information, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical diagnostics instruments and apparatus for the analysis of bodily fluids | ACTIVE | — |
| 042 | Computer-aided diagnostic testing services, namely, proving reagent sample testing and diagnostic services for other for scientific research purposes; Software as a service (SaaS) services featuring software for machine learning, deep learning for use in deep neural networks; Software as a service (SaaS), namely, hosting a computer software platform enabling connectivity and exchange of data between scientific, technical, diagnostic and laboratory devices for the transmission of medical data; Software as a service (SaaS) for early detection, diagnosis, prognosis and treatment of diseases; Scientific and technical consultancy and support for customers purchasing diagnostic software, namely, troubleshooting in the nature of diagnosing computer software problems; Blood analysis; Online non-downloadable computer software and hardware for medical and diagnostic use for monitoring and analyzing patient data points from the health records; Online non-downloadable computer software for evaluating, verifying, monitoring, analysis and management of medical data; Online non-downloadable computer software for medical equipment, in particular in diagnostic and prognostic equipments indicating level risk of sepsis; Online non-downloadable AI software for diagnostics, monitoring and data analysis; Online non-downloadable computer software for use with medical patient monitoring, diagnostic and prognostic equipment for receiving, processing, transmitting, analyzing, organizing and displaying data; Online non-downloadable computer software for enabling the secure and efficient transfer of tests and data between patients and caregivers; Online non-downloadable computer software applications for body fluid monitoring; Online non-downloadable computer software for monitoring, tracking, inserting, archiving, analyzing, preparing of reports, comparing and sharing of medical information and data; Information, advice and consultancy services relating to the aforementioned services | ACTIVE | — |
| 044 | Diagnostic and prognostic medical services; Medical analysis for the diagnosis and treatment of persons; Providing medical information, namely, preparation of medical reports for use in decision-making; Provision of medical information from medical reports for use in decision-making; Medical care, namely monitoring of patients; Medical testing and analysis for diagnostic, prognostic or treatment purposes; Provision of medical information for treatment of individuals; Information and consultancy relating to the analysis of medical data for the treatment of individuals; Providing medical information from remote locations via devices that feed information to the website that is being processed, exchanged and accessed in real time by users for medical staff and medical patients via a website; Consultancy relating to medical health care; Consultancy, advisory and information services relating to all the aforesaid services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 24, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 24, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 16, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 16, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 24, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 23, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 23, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 23, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 19, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 18, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 18, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 18, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 26, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 26, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 26, 2025 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Feb 26, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 20, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 20, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 20, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 20, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 20, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 20, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 20, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 20, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 23, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 24, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 20, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 20, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2022 | NWAP | NEW APPLICATION ENTERED | — |